JOURNAL OF MOLECULAR MEDICINE-JMM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-03-27 ms3552943899811193 来自重庆

投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。

79 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-01-17 周郎来自贵州省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：蛋白翻译后修饰;单基因遗传病
经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。

34 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-03-23 monica77

3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？

184 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-05-07 ms7000001464324828 来自湖南省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：免疫;肿瘤;分子机制
经验分享：22.11.02投稿
22.11.03with editor
22.11.16under review
然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿
23.03.10审稿结束with editor
23.03.18major revision
23.04.26大修返稿 with editor
23.04.27under review审稿人同意二审
23.05.01with editor
23.05.02二审需要修改细节编辑说修改后接收当天二审返修
23.05.04Accept
我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-01-09 15531030

审稿速度:2.0 | 投稿命中率:25.0
经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。
9月初投，
11月初一审意见返回 20几条修改意见小修
12月初加了一个表格，机制图全部重画。修后再投
12月中旬二审意见，其他评委通过，还有一个评委建议小修
12月底修后再投
1月8日通知收稿。

221 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-03-12 这是一个昵称

德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。

176 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-12-14 ms4000000529451557 来自河南省

偏重的研究方向：肿瘤
经验分享：审了7个月给我拒了

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-08-12 14624ce9m23暂无昵称

请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表::
七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表:
七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？

放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？

170 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

哪些期刊是公认的水刊？

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122066, encodeId=98f9212206662, content=投稿快3个月了，还是在 Under Review中，期间写信问过一次，杂志回信说还未收到第二个审稿人的意见，这又过去一个月了，还没有进展，杂志也没有让我新推荐审稿人。这能不能写信建议杂志换审稿人啦？感觉太拖沓了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d41839407, createdName=ms3552943899811193, createdTime=Mon Mar 27 14:45:50 CST 2023, time=2023-03-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2110629, encodeId=6a23211062944, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：蛋白翻译后修饰;单基因遗传病 经验分享：22-08-17投稿，22-12-17一审审完，给了major revision，本来是22-12-26修修回的，但是J Mol Med杂志系统出问题，不能提交修回稿件，23-01-02才提交成功，23-01-17顺利接收。虽然前后花了5个月，但是总的来说，编辑部很负责人，你问的问题都能及时回答，也有耐心。J Mol Med是经典的老牌杂志，审稿严格，性价比都挺高，而且可以不交版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482066161, createdName=周郎, createdTime=Tue Jan 17 21:37:05 CST 2023, time=2023-01-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=587219, encodeId=a5f158e21939, content=3.9投稿，3.13with editor，3.17收到邮件要求提供Western原图，然后就一直是with editor了。在杂志主页上看到平均时间26天有结果，不知道怎么还没有送出外审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6a1643864, createdName=monica77, createdTime=Mon Mar 23 14:47:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130655, encodeId=7b3b2130655f8, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：免疫;肿瘤;分子机制 经验分享：22.11.02投稿 22.11.03with editor 22.11.16under review 然后一直没邀请到审稿人，直到23.02.25审稿人同意审稿 23.03.10审稿结束with editor 23.03.18major revision 23.04.26大修返稿 with editor 23.04.27under review审稿人同意二审 23.05.01with editor 23.05.02二审需要修改细节编辑说修改后接收当天二审返修 23.05.04Accept 我的是7500-8000字左右的非邀请综述，两张图一个表格，感觉编辑和审稿人非常友好，大修问题不多，效率高。主要前期四个月一直没邀请到审稿人，但是我没催稿就一直等，审稿人同意审稿后，返修接收就很快了，只能说好事多磨，个人觉得投稿难度不大，希望能帮助到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ae8324464, createdName=ms7000001464324828, createdTime=Sun May 07 00:57:48 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=565347, encodeId=252556534eee, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非约稿综述，写了7000-8000字，2个表，2个图，参考文献150个，美国bioedit语言润色后投稿。 9月初投， 11月初一审意见返回 20几条修改意见小修 12月初加了一个表格，机制图全部重画。修后再投 12月中旬二审意见，其他评委通过，还有一个评委建议小修 12月底修后再投 1月8日通知收稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a77a1532040, createdName=15531030, createdTime=Wed Jan 09 01:14:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586434, encodeId=761d58643428, content=德国佬杂志，在德国地位不错。比那个JCMM要高。那个杂志估计有点危险。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174957, encodeId=66d421e4957ce, content=偏重的研究方向：肿瘤 经验分享：审了7个月给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db776430639, createdName=ms4000000529451557, createdTime=Thu Dec 14 17:16:05 CST 2023, time=2023-12-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=574694, encodeId=b7b05e469453, content=请问后面是多少天有变化的呢？谢谢放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？放开和放 2018-07-25 08:54:00 发表: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, beContent=放开和放 2018-07-25 发表:: 七月初投的，为何现在还是with editor，正常吗？不是杂志处理挺快的吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/1059765ccd8a40aa986926e2fe3bbf96/a8f6a6380fca49ff8f429655d566033f.jpg, createdBy=71f05115585, createdName=14624ce9m23暂无昵称, createdTime=Mon Aug 12 00:00:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093709, encodeId=0b591093e097a, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093710, encodeId=18e91093e10f8, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

水刊真的不值得选择吗？什么情况下可选择水刊投稿？

82 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务